No Data
No Data
H.C. Wainwright Maintains Caribou Biosciences(CRBU.US) With Buy Rating, Cuts Target Price to $3
HC Wainwright & Co. Maintains Buy on Caribou Biosciences, Lowers Price Target to $3
New Analyst Forecast: $CRBU Given 'Buy' Rating
Express News | Caribou Biosciences, Inc. : H.c. Wainwright Cuts Target Price to $3 From $9
Caribou to Prioritize Lead Cancer Programs in Portfolio Shakeup
Express News | Caribou Biosciences Inc - to Present Data From CB-010 and CB-011 in H2 2025